Rocket Pharmaceuticals Inc. (RCKT)
NASDAQ · Healthcare
Rocket Pharmaceuticals Inc. Net Income 2016–2025
Rocket Pharmaceuticals Inc. annual/quarterly net income history and growth rate from 2016 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Rocket Pharmaceuticals Inc. net income for the quarter ending March 31, 2026 was -47.6 M, a 22.40% decrease year-over-year.
- Rocket Pharmaceuticals Inc. net income for the twelve months ending March 31, 2026 was -228.2 M, a 12.35% decrease year-over-year.
- Rocket Pharmaceuticals Inc. annual net income for 2025 was -223.1 M, a 13.77% decrease from 2024.
- Rocket Pharmaceuticals Inc. annual net income for 2024 was -258.7 M, a 5.35% increase from 2023.
- Rocket Pharmaceuticals Inc. annual net income for 2023 was -245.6 M, a 10.70% increase from 2022.
- Rocket Pharmaceuticals Inc. annual net income for 2022 was -221.9 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Rocket Pharmaceuticals Inc. Net Income — FAQ
Rocket Pharmaceuticals Inc. (RCKT) net income over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is Rocket Pharmaceuticals Inc.'s net income?
Rocket Pharmaceuticals Inc. (RCKT) reported net income of -$223M for fiscal 2025.
Where can I see RCKT's net income history?
The chart and table above show Rocket Pharmaceuticals Inc.'s net income by year and by quarter, including the growth rate.